COVIFIND Rapid Antigen Self test
COVIFIND COVID-19 Antigen Self-Test is an In-Vitro diagnostics immunochromatographic rapid assay kit for the qualitative detection of SARS-CoV-2 specific antigen in nasal swab specimens from symptomatic & asymptomatic individuals. This test is authorised & intended for non-prescription home use as self-test with the self-collected nasal specimens from individuals aged 18 years or older & with adult collected nasal specimens from individuals aged 2 years or older. This test intended to be used as an aid in the diagnosis of SARS-CoV-2 infections. A positive test result should be considered as a true positive & does not need reconfirmation by RT-PCR test. Negative results must be combined with clinical observations, patient history, and epidemiological information. Symptomatic individuals identified negative by Rapid Antigen Test (RAT) should be linked with RT-PCR test facility and subsequently get tested by RT-PCR to rule out COVID-19 infection. In the meantime, such individual will be urged to follow home isolation and treatment as a negative report on RAT may not be true negative in some cases.
COVIFIND Information for Use
The self test is to be used alongside the company’s official home testing mobile application, ‘CoviFind App,’ which will be available to download from the Google Play Store and Apple App Store once the product hits the market. The user-friendly app collects credentials and patient details, ascertains symptoms and offers a guided or quick test administration option. The guided test offers a step-by-step video breakdown of the process.